206 related articles for article (PubMed ID: 12435046)
41. Dendritic cell vaccines in melanoma: from promise to proof?
Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
[TBL] [Abstract][Full Text] [Related]
42. Liposomal vaccines--targeting the delivery of antigen.
Altin JG; Parish CR
Methods; 2006 Sep; 40(1):39-52. PubMed ID: 16997712
[TBL] [Abstract][Full Text] [Related]
43. Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination.
Liu G; Black KL; Yu JS
Expert Rev Vaccines; 2006 Apr; 5(2):233-47. PubMed ID: 16608423
[TBL] [Abstract][Full Text] [Related]
44. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
45. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.
Yannelli JR; Wroblewski JM
Vaccine; 2004 Nov; 23(1):97-113. PubMed ID: 15519713
[TBL] [Abstract][Full Text] [Related]
46. Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma.
Papewalis C; Wuttke M; Jacobs B; Domberg J; Willenberg H; Baehring T; Cupisti K; Raffel A; Chao L; Fenk R; Seissler J; Scherbaum WA; Schott M
Horm Metab Res; 2008 Feb; 40(2):108-16. PubMed ID: 18283628
[TBL] [Abstract][Full Text] [Related]
47. DC-based cancer vaccines.
Gilboa E
J Clin Invest; 2007 May; 117(5):1195-203. PubMed ID: 17476349
[TBL] [Abstract][Full Text] [Related]
48. Modification of dendritic cells with interferon-gamma-inducible protein-10 gene to enhance vaccine potency.
Kang TH; Bae HC; Kim SH; Seo SH; Son SW; Choi EY; Seong SY; Kim TW
J Gene Med; 2009 Oct; 11(10):889-98. PubMed ID: 19618483
[TBL] [Abstract][Full Text] [Related]
49. Delivery of whole tumor lysate into dendritic cells for cancer vaccination.
Liu LN; Shivakumar R; Allen C; Fratantoni JC
Methods Mol Biol; 2008; 423():139-53. PubMed ID: 18370195
[TBL] [Abstract][Full Text] [Related]
50. The immune response to breast cancer, and the case for DC immunotherapy.
Allan CP; Turtle CJ; Mainwaring PN; Pyke C; Hart DN
Cytotherapy; 2004; 6(2):154-63. PubMed ID: 15203992
[TBL] [Abstract][Full Text] [Related]
51. [Dendrite cell-based cancer vaccines--clinical application].
Svane IM; Berntsen A; Trepiakas R; Pedersen AE
Ugeskr Laeger; 2006 Apr; 168(14):1415-20. PubMed ID: 16584668
[TBL] [Abstract][Full Text] [Related]
52. Potentiation strategies of dendritic cell-based antitumor vaccines: combinational therapy takes the front seat.
Torabi-Rahvar M; Bozorgmehr M; Jeddi-Tehrani M; Zarnani AH
Drug Discov Today; 2011 Aug; 16(15-16):733-40. PubMed ID: 21558016
[TBL] [Abstract][Full Text] [Related]
53. Cancer vaccines: an update.
Hipp JD; Hipp JA; Lyday BW; Minev BR
In Vivo; 2000; 14(5):571-85. PubMed ID: 11125541
[TBL] [Abstract][Full Text] [Related]
54. Dendritic cell-based nanovaccines for cancer immunotherapy.
Paulis LE; Mandal S; Kreutz M; Figdor CG
Curr Opin Immunol; 2013 Jun; 25(3):389-95. PubMed ID: 23571027
[TBL] [Abstract][Full Text] [Related]
55. Dendritic cell-based therapy: a review focusing on antigenic selection.
Syme RM; Bryan TL; Glück S
J Hematother Stem Cell Res; 2001 Oct; 10(5):601-8. PubMed ID: 11672506
[TBL] [Abstract][Full Text] [Related]
56. Dendritic-cell tumor vaccines.
Rolinski J; Hus I
Transplant Proc; 2010 Oct; 42(8):3306-8. PubMed ID: 20970677
[TBL] [Abstract][Full Text] [Related]
57. [Dendritic cell-based immunotherapy for multiple myeloma -- review].
Zhu XJ; He L; Sun XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):821-5. PubMed ID: 19549416
[TBL] [Abstract][Full Text] [Related]
58. Dendritic cell-based vaccine research against cancer.
Mody N; Dubey S; Sharma R; Agrawal U; Vyas SP
Expert Rev Clin Immunol; 2015 Feb; 11(2):213-32. PubMed ID: 25467734
[TBL] [Abstract][Full Text] [Related]
59. Dendritic cell vaccines to combat glioblastoma.
Wheeler CJ
Expert Rev Neurother; 2010 Apr; 10(4):483-6. PubMed ID: 20367199
[No Abstract] [Full Text] [Related]
60. [Preparation of dendritic cell tumor-vaccine with dendritic cells and problems in its clinical uses--review].
Yu ZY; Chen H; Feng K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):397-400. PubMed ID: 15228677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]